Avedro Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Avedro Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7519
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-linking; IROC Innocross for ocular pathology; and riboflavin formulations for various cross-linking needs. It also manufactures capital equipment and single dose pharmaceuticals. Averdro’s products are used in the treatment of eye conditions such as keratoconus and corneal ectasia. The company markets its products through a network of ophthalmic medical device distributors and sales representatives for healthcare markets across the US. Averdro is headquartered in Waltham, Massachusetts, the US.

Avedro Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avedro Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avedro Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Avedro Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avedro Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Avedro Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Avedro Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Avedro Acquires Assets of IROC Innocross 11
Avedro Acquires MedioCross Products of Medio-Haus-Medizinprodukte 12
Venture Financing 13
Avedro Raises USD25 Million in Venture Financing 13
Avedro Raises USD42 Million in Equity and Debt Financing 15
Avedro Raises USD12 Million in Venture Financing 16
Avedro Raises USD32 Million in Equity Financing Round 17
Avedro Raises Additional USD7.2 Million in Venture Financing 18
Avedro Raises USD6.5 Million in Venture Financing 19
Avedro Raises US$43 Million In Series D Financing 20
Avedro Raises Additional US$1 Million In Series C Financing 22
Partnerships 24
Avedro Enters into Licensing Agreement with California Institute of Technology 24
Avedro Enters into Licensing Agreement with IROC Innocross 25
Avedro Enters into Licensing Agreement with University of Rostock 26
Avedro Enters Into Licensing Agreement With EyeGate Pharma For Iontophoresis Patents 27
Avedro Enters Into Option Agreement With Cleveland Clinic To License Intellectual Property Assets 28
Avedro Inc – Key Competitors 29
Avedro Inc – Key Employees 30
Avedro Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Corporate Communications 32
Jul 31, 2018: Thomas W. Burns, CEO of Glaukos, Joins Avedro’s Board of Directors 32
Apr 10, 2018: Avedro Names James Schuermann Chief Business Officer 33
Jul 18, 2017: Donald J. Zurbay Joins Avedro’s Board of Directors 34
Jun 20, 2017: Avedro Names Thomas E. Griffin Chief Financial Officer 35
Product News 36
Mar 09, 2017: NVISION Eye Centers Offers First FDA Approved Cross-Linking Procedures on Patients in the U.S. with Progressive Keratoconus 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Avedro Inc, Medical Equipment, Key Facts 2
Avedro Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Avedro Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avedro Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Avedro Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avedro Inc, Deals By Market, 2012 to YTD 2018 8
Avedro Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Avedro Acquires Assets of IROC Innocross 11
Avedro Acquires MedioCross Products of Medio-Haus-Medizinprodukte 12
Avedro Raises USD25 Million in Venture Financing 13
Avedro Raises USD42 Million in Equity and Debt Financing 15
Avedro Raises USD12 Million in Venture Financing 16
Avedro Raises USD32 Million in Equity Financing Round 17
Avedro Raises Additional USD7.2 Million in Venture Financing 18
Avedro Raises USD6.5 Million in Venture Financing 19
Avedro Raises US$43 Million In Series D Financing 20
Avedro Raises Additional US$1 Million In Series C Financing 22
Avedro Enters into Licensing Agreement with California Institute of Technology 24
Avedro Enters into Licensing Agreement with IROC Innocross 25
Avedro Enters into Licensing Agreement with University of Rostock 26
Avedro Enters Into Licensing Agreement With EyeGate Pharma For Iontophoresis Patents 27
Avedro Enters Into Option Agreement With Cleveland Clinic To License Intellectual Property Assets 28
Avedro Inc, Key Competitors 29
Avedro Inc, Key Employees 30
Avedro Inc, Other Locations 31

List of Figures
Avedro Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Avedro Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Avedro Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Avedro Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Avedro Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avedro Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Avedro Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avedro Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Avedro Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Airservices Australia:企業の戦略的SWOT分析
    Airservices Australia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • curasan AG (CURK):企業の財務・戦略的SWOT分析
    curasan AG (CURK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Verbund AG:企業の発電所・SWOT分析2018
    Verbund AG - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Bio-Reference Laboratories Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bio-Reference Laboratories Inc (Bio-Reference) a subsidiary of Opko Health, Inc., is a full service clinical laboratory that specializes in genetic testing. The company provides comprehensive range of tests that focus on molecular diagnostics, genetics, anatomical pathology, oncology, and wo …
  • Logan Resources Ltd:企業の戦略・SWOT・財務情報
    Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • IC Group A/S:企業の戦略・SWOT・財務情報
    IC Group A/S - Strategy, SWOT and Corporate Finance Report Summary IC Group A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ridley Corporation Ltd:企業の戦略・SWOT・財務分析
    Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Henry Lamotte Group:戦略・SWOT・企業財務分析
    Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report Summary Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Epic Systems Corp:企業の戦略的SWOT分析
    Epic Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Chevron Nigeria Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Nigeria Ltd (Chevron Nigeria) a subsidiary of Chevron Corporation is an oil and gas company that offers exploration, production and transportation of crude oil and natural gas. The company distributes products such as additives, jet fuels, base oil, chemical, fuel, lubricant, marine …
  • Grunenthal GmbH:企業の戦略的SWOT分析
    Grunenthal GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Bial – Portela & Ca SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Bial - Portela & Ca SA (BIAL) is a pharmaceutical company that discovers, develops and provides drugs for neurosciences and cardiovascular therapeutic areas. The company offers products such as anti-inflammatories, anti-diabetics, cardiovascular, anti-asthmatics, antibiotics, antidepressants …
  • Cosmo Pharmaceuticals NV (COPN):医療機器:M&Aディール及び事業提携情報
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Bryce Corporation:企業の戦略・SWOT・財務情報
    Bryce Corporation - Strategy, SWOT and Corporate Finance Report Summary Bryce Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Invictus Oncology Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Invictus Oncology Pvt Ltd (Invictus Oncology) is a biopharmaceutical company with focus on the discovery, development and commercialization of anti-cancer drugs. The company develops platinum-based drugs to treat various types of cancers. It engineers platinum-based drugs harnessing structur …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Adynxx Inc (ADYX):企業の財務・戦略的SWOT分析
    Summary Adynxx Inc (Adynxx), formerly known as Alliqua BioMedical, Inc, is a clinical stage biopharmaceutical company. It utilizes AYX transcription factor decoys to create therapies with disease changing properties. The company is involved in the development of transcription factor decoy technology …
  • Fujitsu Australia Ltd:企業の戦略的SWOT分析
    Fujitsu Australia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Faron Pharmaceuticals Oy (FARN)-製薬・医療分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • NBCUniversal Media LLC:企業の戦略・SWOT・財務情報
    NBCUniversal Media LLC - Strategy, SWOT and Corporate Finance Report Summary NBCUniversal Media LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆